Systém multiparametrový HumaSens Plus Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

systém multiparametrový humasens plus

human gesellschaft für biochemica und diagnostica gmbh max-planck-ring 21 65205 wiesbaden nemecko -

Test IVD súprava EDI Human Chromogranín A ELISA kit Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

test ivd súprava edi human chromogranín a elisa kit

epitope diagnostics, inc. 8940 activity rd., suite g 92126 san diego, california spojené štáty americké -

Nástroj laparoskopický HandX Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nástroj laparoskopický handx

human xtensions ltd. grand netter building, meir ariel strasse 4 4250574 netanya izrael -

Vocabria Európska únia - slovenčina - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcie - antivirotiká na systémové použitie - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Európska únia - slovenčina - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vakcíny - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

Skysona Európska únia - slovenčina - EMA (European Medicines Agency)

skysona

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - Ďalšie lieky na nervový systém - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Oxbryta Európska únia - slovenčina - EMA (European Medicines Agency)

oxbryta

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.